Alector (ALEC) Change in Account Payables (2018 - 2026)
Alector's (ALEC) quarterly Change in Account Payables came in at $860000.0 in Q2 2026, up 888.99% year-over-year from $86957.3 in Q2 2025, and up 420.9% quarter-over-quarter from -$268000.0 in Q1 2026.
Analysis
Alector (ALEC) Change in Account Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Account Payables for 9 consecutive years, with $860000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 888.99% year-over-year to $860000.0 in Q2 2026; TTM through Jun 2026 was $66000.0, a 103.17% increase from a year earlier, with the FY2025 full-year figure at -$524000.0, up 63.64% from the prior year.
- Change in Account Payables was $860000.0 for Q2 2026 at Alector, up from -$268000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.5 million in Q3 2025 and troughed at -$3.1 million in Q4 2025.
- A 5-year average of -$129000.0 and a median of -$52500.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables plunged 437.04% in 2023 and surged 17150.0% in 2024, its largest moves.
- Over 5 years, Change in Account Payables stood at -$189000.0 in 2022, then sank by 437.04% to -$1.0 million in 2023, then plunged by 173.3% to -$2.8 million in 2024, then retreated by 10.53% to -$3.1 million in 2025, then surged by 128.05% to $860000.0 in 2026.
- The last three Change in Account Payables figures came in at $860000.0 (Q2 2026), -$268000.0 (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -70.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 18.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -66.70 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -8.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 860,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 860,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 690,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Dec 31, 2023 | -1.02 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | -914,000.00 |
| Dec 31, 2022 | -189,000.00 |
| Sep 30, 2022 | 147,000.00 |
| Jun 30, 2022 | -2.57 Mn |
| Mar 31, 2022 | 2.04 Mn |
| Dec 31, 2021 | 2.26 Mn |
| Sep 30, 2021 | -9.50 Mn |